[1] SEXTON R E,Al HALLAK M N,DIAB M,et al.Gastric cancer:a comprehensive review of current and future treatment strategies[J].Cancer Metastasis Rev,2020,39(4):1179-1203.
[2] LOTT P C,CARVAJAL-CARMONA L G.Resolving gastric cancer aetiology:an update in genetic predisposition[J].Lancet Gastroenterol,2018,3(12):874-883.
[3] JOSHI S S,BADGWELL B D.Current treatment and recent progress in gastric cancer[J].CA Cancer J Clin,2021,71(3):264-279.
[4] MACHLOWSKA J,BAJ J,SITARZ M,et al.Gastric cancer:epidemiology,risk factors,classification,genomic characteristics and treatment strategies[J].Int J Mol Sci,2020,21(11):4012.
[5] CAVATORTA O,SCIDA S,MIRAGLIA C,et al.Epidemiology of gastric cancer and risk factors[J].Acta Biomed,2018,89(8-S):82-87.
[6] SCHRÖCK A,LEISSE A,De VOS L,et al.Free-circulating methylated DNA in blood for diagnosis,staging,prognosis,and monitoring of head and neck squamous cell carcinoma patients:an observational prospective cohort study[J].Clinical Chemistry,2017,63(7):1288-1296.
[7] KRAUSEWITZ P,KLUEMPER N,RICHTER A P,et al.Early dynamics of quantitative SEPT9 and SHOX2 methylation in circulating cell-free plasma DNA during prostate biopsy for prostate cancer diagnosis[J].Cancers,2022,14(18):4355.
[8] KANG N,MATSUI T S,LIU S,et al.ARHGAP4-SEPT2-SEPT9 complex enables both up-and down-modulation of integrin-mediated focal adhesions,cell migration,and invasion[J].Mol Biol Cell,2021,32(21):ar28.
[9] WEI J,LI G,ZHANG J,et al.Integrated analysis of genome-wide DNA methylation and gene expression profiles identifies potential novel biomarkers of rectal cancer[J].Oncotarget,2016,7(38):62547.
[10] SHEN N,WANG T,LI D,et al.Hypermethylation of the SEPT9 gene suggests significantly poor prognosis in cancer patients:a systematic review and meta-analysis[J].Front Genet,2019,10:887.
[11] ABDI E,LATIFI-NAVID S,ABEDI SARVESTANI F,et al.Emerging therapeutic targets for gastric cancer from a host-Helicobacter pylori interaction perspective[J].Expert Opin Ther Targets,2021,25(8):685-699.
[12] SHEWEITA S A,ALSAMGHAN A S.Molecular mechanisms contributing bacterial infections to the incidence of various types of cancer[J].Mediators Inflamm,2020,2020:4070419.
[13] OU Y,REN H,ZHAO R,et al.Helicobacter pylori CagA promotes the malignant transformation of gastric mucosal epithelial cells through the dysregulation of the miR-155/KLF4 signaling pathway[J].Molecular Carcinogenesis,2019,58(8):1427-1437.
[14] CHOI R S Y,LAI W Y X,LEE L T C,et al.Current and future molecular diagnostics of gastric cancer[J].Expert Rev Mol Diagn,2019,19(10):863-874.
[15] BAUER M,NASCAKOVA Z,MIHAI A I,et al.The ALPK1/TIFA/NF-κB axis links a bacterial carcinogen to R-loop-induced replication stress[J].Nature Communications,2020,11(1):5117.
[16] CAMARGO M C,MURPHY G,KORIYAMA C,et al.Determinants of Epstein-Barr virus-positive gastric cancer:an international pooled analysis[J].British Journal of Cancer,2011,105(1):38-43.
[17] TAVAKOLI A,MONAVARI S H,MOHAMMADI F S,et al.Association between Epstein-Barr virus infection and gastric cancer:a systematic review and meta-analysis[J].BMC Cancer,2020,20(1):493.
[18] STANLAND L J,LUFTIG M A.The role of EBV-induced hypermethylation in gastric cancer tumorigenesis[J].Viruses,2020,12(11):1222.
[19] THRIFT A P,EL-SERAG H B.Burden of gastric cancer[J].Clinical Gastroenterology and Hepatology,2020,18(3):534-542.
[20] EUSEBI L H,TELESE A,MARASCO G,et al.Gastric cancer prevention strategies:a global perspective[J].Journal of Gastroenterology and Hepatology,2020,35(9):1495-1502.
[21] LADEIRAS-LOPES R,PEREIRA A K,NOGUEIRA A,et al.Smoking and gastric cancer:systematic review and meta-analysis of cohort studies[J].Cancer Causes Control,2008,19(7):689-701.
[22] YANG L,YING X,LIU S,et al.Gastric cancer:epidemiology,risk factors and prevention strategies[J].Chinese Journal of Cancer Research,2020,32(6):695-704.
[23] TRAMACERE I,NEGRI E,PELUCCHI C,et al.A meta-analysis on alcohol drinking and gastric cancer risk[J].Annals of Oncology,2012,23(1):28-36.
[24] SALMAN M A,ABDALLAH A,MIKHAIL H M S,et al.Long-term impact of mini-gastric bypass on inflammatory cytokines in cohort of morbidly obese patients:a prospective study[J].Obesity Surgery,2020,30(6):2338-2344.
[25] KARIMI P,ISLAMI F,ANANDASABAPATHY S,et al.Gastric cancer:descriptive epidemiology,risk factors,screening,and prevention gastric cancer[J].Cancer Epidemiol Biomarkers Prev,2014,23(5):700-713.
[26] CLINTON S K,GIOVANNUCCI E L,HURSTING S D.The world cancer research fund/American institute for cancer research third expert report on diet,nutrition,physical activity,and cancer:impact and future directions[J].J Nutr,2020,150(4):663-671.
[27] CHANG C J,TU Y K,CHEN P C,et al.Talc exposure and risk of stomach cancer:systematic review and meta-analysis of occupational cohort studies[J].J Formos Med Assoc,2020,119(4):781-792.
[28] WANG Y,CHEN P M,LIU R B.Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detection[J].World J Gastro Oncol,2018,10(1):15-22.
[29] HARIHARAN R,JENKINS M.Utility of the methylated SEPT9 test for the early detection of colorectal cancer:a systematic review and meta-analysis of diagnostic test accuracy[J].BMJ Open Gastroenterol,2020,7(1):e000355.
[30] ZENG Y,CAO Y,LIU L,et al.SEPT9_i1 regulates human breast cancer cell motility through cytoskeletal and RhoA/FAK signaling pathway regulation[J].Cell Death Disease,2019,10(10):1-16.
[31] AMIR S,WANG R,MATZKIN H,et al.MSF-A interacts with hypoxia-inducible factor-1α and augments hypoxia-inducible factor transcriptional activation to affect tumorigenicity and angiogenesis[J].Cancer Research,2006,66(2):856-866.
[32] SUN J,ZHENG M,LI Y,et al.Structure and function of Septin 9 and its role in human malignant tumors[J].World J Gastro Oncol,2020,12(6):619-631.
[33] KOCH A,JOOSTEN S C,FENG Z,et al.Analysis of DNA methylation in cancer:location revisited[J].Nat Rev Clin Oncol,2018,15(7):459-466.
[34] SUN J,ZHENG M Y,LI Y W,et al.Structure and function of Septin 9 andits role in human malignant tumors[J].World J Gastro Oncol,2020,12(6):619.
[35] ZHOU H,DONG A,XIA H,et al.Associations between CA19-9 and CA125 levels and human epidermal growth factor receptor 2 overexpression in patients with gastric cancer[J].Oncology Letters,2018,16(1):1079-1086.
[36] YIN L K,SUN X Q,MOU D Z.Value of combined detection of serum CEA,CA72-4,CA19-9 and TSGF in the diagnosis of gastric cancer[J].Asian Pacific Journal of Cancer Prevention,2015,16(9):3867-3870.
[37] LI X,LI S,ZHANG Z,et al.Association of multiple tumor markers with newly diagnosed gastric cancer patients:a retrospective study[J].Peer J,2022,10:e13488.
[38] PETERSON E A,STANBERY L,LI C,et al.SEPT9_i1 and genomic instability:mechanistic insights and relevance to tumorigenesis[J].Genes Chromosomes Cancer,2011,50(11):940-949.
[39] SONG L,CHEN Y,GONG Y,et al.Opportunistic screening and survival prediction of digestive cancers by the combination of blood mSEPT9 with protein markers[J].Ther Adv Med Oncol,2020(12):1-16.
[40] FU B,YAN P,ZHANG S,et al.Cell-free circulating methylated SEPT9 for noninvasive diagnosis and monitoring of colorectal cancer[J].Disease Markers,2018,2018:6437104.
[41] CAO C Q,CHANG L,WU Q.Circulating methylated Septin 9 and ring finger protein 180 for noninvasive diagnosis of early gastric cancer[J].Translational Cancer Research,2020,9(11):7012-7021. |
